Demega Formulations and Exports

Triohale Rotacaps Capsules

Triohale Rotacaps Capsules
Business Type Manufacturer, Exporter
Port Mumbai
Payment Terms T/T, Western Union, MoneyGram
Delivery Time 5 - 7 working days

Preferred Buyer From

Location All Countries Except India

We are situated in Nagpur(India) and we have a well-developed network that assists us in reaching any destination. Backed by a well-established warehouse, we are able to store the products in a secured manner. Thus, we ensure complete security of the products from any kind of damage. Triohale Rotacaps Capsules is used for the treatment of chronic obstructive pulmonary disease.

 

Details :

  • Formoterol or eformoterol is a long-acting β2-agonist used in the management of asthma and/or chronic obstructive pulmonary disease (COPD). It is marketed in four forms: a dry-powder inhaler (DPI), metered dose inhaler (MDI), an oral tablet, and as an inhalation solution, under various trade names including Foradil/Foradile (Schering-Plough in the U.S., Novartis rest of world), Oxeze (AstraZeneca), Atock (Astellas), Atimos Modulite (Trinity-Chiesi) and Perforomist (Dey).
  • Formoterol is a long-acting β2 agonist (LABA), which has an extended duration of action (up to 12 hours) compared to short-acting β2 agonists such as salbutamol, which have are effective for 4–6 hours. LABAs such as formoterol are used as "symptom controllers" to supplement prophylactic corticosteroid therapy (e.g. fluticasone). A "reliever" short-acting β2 agonist (e.g. salbutamol) is still required, since LABAs are not recommended for the treatment of acute asthma.

Yes! I am interested

Looking for "Triohale Rotacaps Capsules" ?

Explore More Products



Raise your Query

Hi! Simply click below and type your query.

Our experts will reply you very soon.

WhatsApp Us